Lexaria Bioscience Corp Performance

The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Lexaria Bioscience are completely uncorrelated.

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Lexaria Bioscience Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Lexaria Bioscience is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors. ...more
Quick Ratio7.20
Fifty Two Week Low0.1700
Fifty Two Week High0.5600
  

Lexaria Bioscience Relative Risk vs. Return Landscape

If you would invest (100.00) in Lexaria Bioscience Corp on December 29, 2023 and sell it today you would earn a total of  100.00  from holding Lexaria Bioscience Corp or generate -100.0% return on investment over 90 days. Lexaria Bioscience Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than Lexaria, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Lexaria Bioscience Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Lexaria Bioscience's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Lexaria Bioscience Corp, and traders can use it to determine the average amount a Lexaria Bioscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
LXRP
Based on monthly moving average Lexaria Bioscience is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lexaria Bioscience by adding Lexaria Bioscience to a well-diversified portfolio.

Lexaria Bioscience Fundamentals Growth

Lexaria OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Lexaria Bioscience, and Lexaria Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lexaria OTC Stock performance.

Things to note about Lexaria Bioscience Corp performance evaluation

Checking the ongoing alerts about Lexaria Bioscience for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Lexaria Bioscience Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Lexaria Bioscience is not yet fully synchronised with the market data
Lexaria Bioscience has some characteristics of a very speculative penny stock
Lexaria Bioscience has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 384.54 K. Net Loss for the year was (3.93 M) with profit before overhead, payroll, taxes, and interest of 276.93 K.
Lexaria Bioscience Corp currently holds about 1.31 M in cash with (2.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Evaluating Lexaria Bioscience's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Lexaria Bioscience's otc stock performance include:
  • Analyzing Lexaria Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lexaria Bioscience's stock is overvalued or undervalued compared to its peers.
  • Examining Lexaria Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Lexaria Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lexaria Bioscience's management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of Lexaria Bioscience's otc stock. These opinions can provide insight into Lexaria Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Lexaria Bioscience's otc stock performance is not an exact science, and many factors can impact Lexaria Bioscience's otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Consideration for investing in Lexaria OTC Stock

If you are still planning to invest in Lexaria Bioscience Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lexaria Bioscience's history and understand the potential risks before investing.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments